Company Filing History:
Years Active: 2012
Title: Thomas Litman: Innovator in Cancer Diagnostics
Introduction
Thomas Litman is a notable inventor based in Værløse, Denmark. He has made significant contributions to the field of cancer research through his innovative work on human microRNAs. His research focuses on developing molecular markers that can aid in cancer diagnostics and therapeutic applications.
Latest Patents
Thomas Litman holds a patent titled "Human microRNAs associated with cancer." This invention provides new sequences for human microRNAs that are linked to cancer. These sequences may serve as molecular markers for cancer diagnostics or as potential therapeutic targets or agents. He has 1 patent to his name, showcasing his commitment to advancing cancer research.
Career Highlights
Throughout his career, Thomas has been associated with Exiqon A/S, a company dedicated to providing innovative solutions in the field of molecular diagnostics. His work at Exiqon has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Thomas has worked alongside notable colleagues such as Søren Møller and Søren Morgenthaler Echwald. Their collaborative efforts have furthered the understanding of microRNAs and their implications in cancer.
Conclusion
In summary, Thomas Litman is a distinguished inventor whose work on human microRNAs has the potential to revolutionize cancer diagnostics and treatment. His contributions to the field are invaluable and highlight the importance of innovation in medical research.